These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34977165)

  • 1. Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.
    Mittal A; Garg R; Bahl A; Khullar M
    Front Cardiovasc Med; 2021; 8():725532. PubMed ID: 34977165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
    Heather LC; Gopal K; Srnic N; Ussher JR
    Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes.
    Khullar M; Cheema BS; Raut SK
    Front Endocrinol (Lausanne); 2017; 8():237. PubMed ID: 29085333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers.
    Prandi FR; Lecis D; Illuminato F; Milite M; Celotto R; Lerakis S; Romeo F; Barillà F
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.
    Pappachan JM; Varughese GI; Sriraman R; Arunagirinathan G
    World J Diabetes; 2013 Oct; 4(5):177-89. PubMed ID: 24147202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Mechanisms in Diabetic Cardiomyopathy.
    Gollmer J; Zirlik A; Bugger H
    Diabetes Metab J; 2020 Feb; 44(1):33-53. PubMed ID: 32097997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy: Emerging therapeutic options.
    Fernandez CJ; Shetty S; Pappachan JM
    World J Diabetes; 2024 Aug; 15(8):1677-1682. PubMed ID: 39192854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.
    Salvatore T; Pafundi PC; Galiero R; Albanese G; Di Martino A; Caturano A; Vetrano E; Rinaldi L; Sasso FC
    Front Med (Lausanne); 2021; 8():695792. PubMed ID: 34277669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weighted Gene Co-Expression Network Analysis Identifies ANGPTL4 as a Key Regulator in Diabetic Cardiomyopathy
    Dai L; Xie Y; Zhang W; Zhong X; Wang M; Jiang H; He Z; Liu X; Zeng H; Wang H
    Front Endocrinol (Lausanne); 2021; 12():705154. PubMed ID: 34616362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
    Borghetti G; von Lewinski D; Eaton DM; Sourij H; Houser SR; Wallner M
    Front Physiol; 2018; 9():1514. PubMed ID: 30425649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomics Coupled to Proteomics Reveals Novel Targets for the Protective Role of Spermine in Diabetic Cardiomyopathy.
    Wei C; Song T; Yuan H; Li X; Zhang X; Liang X; Fan Y
    Oxid Med Cell Longev; 2022; 2022():5909378. PubMed ID: 35437457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
    Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
    Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy.
    Frustaci A; Ciccosanti F; Chimenti C; Nardacci R; Corazzari M; Verardo R; Ippolito G; Petrosillo N; Fimia GM; Piacentini M
    Int J Cardiol; 2016 Jan; 203():282-9. PubMed ID: 26519687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.
    Deng J; Liao Y; Liu J; Liu W; Yan D
    Front Cell Dev Biol; 2021; 9():777258. PubMed ID: 35004678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy.
    Ni T; Huang X; Pan S; Lu Z
    J Cell Mol Med; 2021 Nov; 25(21):9995-10007. PubMed ID: 34609043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.
    De Rosa S; Arcidiacono B; Chiefari E; Brunetti A; Indolfi C; Foti DP
    Front Endocrinol (Lausanne); 2018; 9():2. PubMed ID: 29387042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of histone methylation and acetylation modifiers in cardiac hypertrophy.
    Qin J; Guo N; Tong J; Wang Z
    J Mol Cell Cardiol; 2021 Oct; 159():120-129. PubMed ID: 34175302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System.
    Nagori A; Segar MW; Keshvani N; Patel L; Patel KV; Chandra A; Willett D; Pandey A
    J Diabetes Sci Technol; 2023 Dec; ():19322968231212219. PubMed ID: 38063209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.